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Abstract
Signaling and transcription are tightly integrated processes that underlie many cellular responses
to the environment. A network of signaling events, often mediated by post-translational
modification on proteins, can lead to long-term changes in cellular behavior by altering the
activity of specific transcriptional regulators and consequently the expression level of their
downstream targets. As many high-throughput, “-omics” methods are now available that can
simultaneously measure changes in hundreds of proteins and thousands of transcripts, it should be
possible to systematically reconstruct cellular responses to perturbations in order to discover
previously unrecognized signaling pathways.
This chapter describes a computational method for discovering such pathways that aims to
compensate for the varying levels of noise present in these diverse data sources. Based on the
concept of constraint optimization on networks, the method seeks to achieve two conflicting aims:
(1) to link together many of the signaling proteins and differential expressed transcripts identified
in the experiments (“constraints”) using previously reported protein-protein and protein-DNA
interactions, while (2) keeping the resulting network small and ensuring it is composed of the
highest confidence interactions (“optimization”). A further distinctive feature of this approach is
the use of transcriptional data as evidence of upstream signaling events that drive changes in gene
expression, rather than as proxies for downstream changes in the levels of the encoded proteins.
We recently demonstrated that by applying this method to phosphoproteomic and transcriptional
data from the pheromone response in yeast, we were able to recover functionally coherent
pathways and to reveal many components of the cellular response that are not readily apparent in
the original data. Here we provide a more detailed description of the method, explore the
robustness of the solution to the noise level of input data and discuss the effect of parameter
values.
I. Introduction
One of the central challenges for systems biology is the reconstruction of cellular processes
from high-throughput experimental data. Much of the early work in this area was driven by
the development of microarray technologies that allowed relatively comprehensive
measurement of changes in mRNA expression. Using these data as proxies for changes at
the protein level has generated many insights into the regulatory networks of the cell
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(Spellman et al. 1998; Segal et al. 2005; Ozsolak et al. 2011). However, the actual
correlation between the transcriptome and the proteome is unclear (Schwanhässer et al.
2011; Maier et al. 2009; de Sousa Abreu et al. 2009), and more direct proteomic data are
likely to provide a more reliable and thorough view of cellular processes.
Recently, technological advances have made it possible to directly measure proteomic
changes at the global level. Mass-spectrometry (MS) techniques can quantify the relative
levels of hundreds of peptides across multiple biological conditions (Choudhary et al. 2010;
White 2008) and focused data collection on phosphoproteins was able to reveal the
regulatory dynamics of cellular signaling networks at the level of the proteome (Grimsrud et
al. 2010; Macek et al. 2009; Yi Zhang et al. 2007).
With new data come new challenges. Even in the best characterized responses there is poor
overlap between hits identified by phosphoproteomics technologies and known pathway
components. For example, in a study of phosphorylation changes that occur in response to
mating pheromone in yeast (Gruhler et al. 2005), 112 proteins contain differentially
phosphorylated sites; of these, only 11 are known components of the expected mitogen-
activated protein kinase (MAPK) cascade that responds to pheromone, and 76 were not
present in any of the yeast pathways annotated in the KEGG PATHWAY database
(Kanehisa et al. 2010). Finding new ways to interpret these data could reveal previously
unrecognized cellular pathways.
A second important challenge is to integrate transcriptional and proteomic data in order to
observe the interplay between different layers of cellular signaling. For example, it may be
possible to detect proteomic changes in signal transduction cascades that drive expression
and also to reveal the resulting feedback of transcription on the proteome. But integrating
these data will require novel computational approaches. Because regulation is mediated by
diverse mechanisms, even the most comprehensive proteomics technologies cannot capture
all these events. For example, MS based methods focusing on protein phosphorylation will
fail to detect changes in other post-translational modifications such as acetylation,
ubiquitination and sumoylation. Computational techniques are needed to discover proteins
that participate in the signaling networks but are undetected in the experiments and also to
provide insight into their functional roles. One successful approach has been to map these
proteins onto known metabolic and regulatory pathways such as those curated in the KEGG
PATHWAY (Kanehisa et al. 2010) and Reactome (Matthews et al. 2009) databases. This
approach can reveal functional coherence and relevant biological processes from the data.
However, as mentioned above, a large fraction of the phosphoproteomic data do not map to
known pathway models, so we must turn to other approaches.
The interactome provides an alternative to using well-studied pathways. Advances in high-
throughput experimental mapping of protein-protein interactions as well as efforts to extract
known interactions from the literature have produced a number of large databases of protein
interactions (selected examples are listed in Table I). Despite being incomplete, especially
for higher organisms, the amount of interaction data in these databases is still very large.
Thus, it may be possible to discover unknown pathways among these interactions. While
utilizing these large interactome datasets improves our ability to find connections among a
set of proteins of interest, it also presents several challenges. First, the size of the potential
network explodes exponentially and quickly becomes non-interpretable, as pointed out by
previous data integration efforts (Hwang et al. 2005). Secondly, interaction records in
databases come from hundreds of laboratories and many experimental techniques of varying
degrees of reliability (von Mering et al. 2002), so overall the data quality is heterogeneous
and should not be treated indiscriminately. Lastly, pooling these interactions together risks
losing the specific context under which they were detected. It is with these issues in mind
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that we propose a constraint optimization approach for finding regulatory networks that are
interpretable, reliable and biologically relevant.
Our method starts with a collection of protein-protein and protein-DNA interactions, which
represent known or experimentally determined signaling and regulatory connections. It
considers the observed phosphorylation events and differential gene expression as
connectivity constraints that the reconstructed network must satisfy. Additionally, we take
into account the different confidence levels among the interaction data sources by
preferentially selecting the more reliable interactions. We show that these objectives can be
formulated as a constraint network optimization problem, in particular, as a prize-collecting
Steiner tree (PCST) problem on the interactome graph. Since the interactions are not limited
to known pathways and the phosphorylation events and differential expressed genes are not
limited to known players in these pathways, there is great potential for novel discoveries. On
the other hand, all the interactions were experimentally determined and therefore have
mechanistic basis that might become relevant in the current context. These two features of
the method strike a balance between finding novel connections and revealing the relevance
of known connections. We hypothesize that since each of our input data sources provides a
different view of the molecular regulatory network, by putting them together we can
generate high confidence hypotheses that have biological relevance and can be tested
experimentally. This framework serves to organize these heterogeneous datasets and
enhance our understanding of the cell at the systems level.
II. Computational methods
Network optimization is an area of computer science that has recently become very useful
for analyzing biological problems, and a variety of algorithms are available to solve specific
optimizations. The problem we have posed consists of finding a set of edges of minimum
weight in order to connect a defined set of nodes (known as termini) in a weighted network.
This problem is called the Steiner tree problem. An important generalization that allows
some terminal nodes to be excluded is known as the prize-collecting Steiner tree (PCST)
problem. For our purpose, we will use a network in which edge weights reflect our
confidence in the interactions and where terminal nodes represent hits from the experiments,
i.e., phosphorylated proteins and differentially expressed transcripts. In this setting, the
solution to the PCST optimization is a set of most confident interactions that link together
the hits while possibly leaving some unconnected [Figure 1(A)].
Although the concept of Steiner tree has been previously applied to biological networks
(Dittrich et al. 2008; Scott et al. 2005), we note that our approach is distinctive in multiple
aspects. First, instead of mRNA transcript abundance we use protein level measurements on
nodes in the interactome, which provides a much more accurate representation of the
underlying biological processes. Second, we explicitly model the confidence of individual
edges in the interactome to account for the uncertainties in the interaction data. Third, we do
not require all nodes in the solution to be detected in the experiments, allowing our approach
to compensate for multiple sources of noise. This last feature is absent in an application of a
Steiner tree like algorithm to build a high confidence network with genetic screening hits as
terminal nodes (Yosef et al. 2009). A minimum-cost flow optimization approach connects
genetic hits to differentially expressed genes (Lan et al. 2011; Yeger-Lotem et al. 2009) but
the result is less compact than the PCST (Huang et al. 2009). We now describe the process
of constructing the optimization problem, solving it and analyzing the results. We also offer
some advice on practical matters such as tuning the parameter values and visualizing the
network.
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A. Setting up the prize-collecting Steiner tree
We treat the interactome as an undirected graph G = (V, E) where nodes are proteins or
genes and edges represent the known interactions. Each node ν ∈ V is associated with a
penalty πν ≥ 0. Protein nodes to which experimental data are mapped receive positive
penalty values and therefore are termini for the PCST. All other nodes receive zero
penalties. As the magnitude of the penalty value increases the more confident we are that the
protein/gene was experimentally detected as relevant in the signaling response. The
algorithm is forced to pay a penalty each time it leaves a terminal out of its final network.
This constraint causes the network to include as many high-confidence nodes as possible.
However, this constraint alone would lead to very large networks that might contain many
unreliable edges. So we also assign to each edge e ∈ E a cost ce ≥ 0 that is inversely related
to our confidence in each interaction.
We aim to find a subtree F = (VF,EF) of G that minimizes the objective function
Because we incur penalties for excluding nodes while paying costs for including edges, the
algorithm will be forced to favor connecting high-confidence data with high-confidence
interactions. We further introduce a scaling parameter β to balance the penalties and the
edge costs:
We may solve this optimization problem exactly by using the branch-and-cut approach
(Ljubić et al. 2005) implemented in the dhea-code software program that calls the ILOG
CPLEX mathematical programming solver. As an alternative to solving it as an integer
linear program, an approach from statistical physics (Bayati et al. 2008) has resulted in new
heuristic algorithms based on message-passing techniques (Bailly-Bechet et al. 2011). We
now describe how the experimental data are transformed into input for the algorithm. An
overview of the work flow is in Figure 1(B).
B. A probabilistic interactome
This is Step 1 in Figure 1(B). The set of edges E of the input graph G consists of direct
(physical) protein-protein interactions found in databases of molecular interactions such as
those listed in Table I. To assign confidence values for these interactions, a few methods
have been previously published (Razick et al. 2008; Orchard et al. 2007; Jansen et al. 2003).
Here we use a naïe Bayes probabilistic model (Jansen et al. 2003). Interaction between two
proteins is modeled as random variable i ∈ {0,1} with i = 1 when two proteins interact and i
= 0 otherwise, and each kind of experimental evidence is modeled as a random variable fj ∈
{0,1} where fj = 1 indicates fj is observed and fj = 0 otherwise. From published gold standard
sets of positive (Yu et al. 2008) and negative interactions (Jansen et al. 2003) we can
compute the conditional probability table for each kind of evidence, P(fj|i). Then, for each
interaction e supported by a set of experimental evidence Fe = {fe,j|j = 1,…, n}, assuming
independence between the evidence we have
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and a straight forward application of Bayes rule gives the probability that this interaction is
real:
The cost ce on edge e that is input into the PCST objective function is
C. Determining transcription factor targets
Transcription factor to mRNA target relationships are added to the protein-protein
interactome to form the total interactome [Step 2 in Figure 1(B)]. A variety of experimental,
computational techniques and combinations of both are possible. For yeast, there are
published genome-wide binding sites for almost all the transcriptional regulators under
multiple conditions measured by chromatin immunoprecipitation (ChIP) experiments
(Harbison et al. 2004; MacIsaac, T. Wang, et al. 2006). The human and mouse ENCODE
projects (Birney et al. 2007) represent systematic efforts to generate ChIP profiles for
multiple transcription factors in a variety of human cell lines and mouse tissues.
Computationally, transcription factors often have sequence specificities that allow binding
sites to be predicted to some extent (Figure 6). Commonly used quantitative representation
of such binding patterns, also known as sequence motifs, include position weight matrices
(PWM)/position specific scoring matrices (PSSM) (D’haeseleer 2006; Stormo 2000) with an
information theoretic perspective, and position specific affinity matrices (PSAM) with a
statistical mechanics perspective (Foat et al. 2006, 2005; Manke et al. 2008; Roider et al.
2007). Motifs from the TRANSFAC (Wingender 2008; Matys et al. 2006) and JASPAR
(Sandelin et al. 2004; Bryne et al. 2008) databases, which collect published transcription
factor binding motifs from the literature, can be used for predicting regulatory elements.
Once a genomic region is determined to be bound by a transcription factor based on
experimental and/or computational evidence, nearby genes can be associated with this factor
as its potential downstream targets, and we add to the interactome edges going from the
transcription factor (a protein node) to these target mRNA nodes.
D. Node penalties
This is Step 3 in Figure 1(B). We define two kinds of penalties for proteins in the
interactome: one at the protein level derived from the phosphoproteomics MS data, and the
other at the mRNA level derived from mRNA expression data.
Although published phosphoproteomic MS datasets often provide the identities of the
proteins that contain the peptide sequences inferred from the MS spectra, it is still advisable
to map the peptides to a database of protein sequences from which the interactome dataset is
derived in order to avoid issues such as inconsistencies in mapping gene identifiers and in
treating protein isoforms. This can be achieved by finding protein sequences in a database
that contain matches to the peptide sequences, for example, by the sequence alignment
search tool BLAST (Altschul et al. 1990) with parameter settings optimized for matching
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short peptide sequences. In an analysis comparing two conditions, proteins that contained
perfect alignment to a peptide sequence receive a positive penalty value that is proportional
to the absolute value of log fold change in phosphorylation between the conditions of
interest. If one peptide sequence is aligned to multiple proteins in the interaction graph, all
these proteins receive the same penalty value. If multiple phosphorylated peptide sequences
are perfectly aligned to one protein, the maximum fold change in phosphorylation of these
peptides is used to calculate the penalty value for this protein. Other methods of assigning
penalties are also possible and are discussed below.
For penalty values on mRNA nodes, some modifications to the interactome are required to
make the resulting network more biologically realistic. If we simply put penalty values on
the mRNA nodes, the tree structure of the solution network means that any one mRNA node
is connected to at most one upstream transcription factor. Such a network cannot capture one
gene being targeted by multiple transcription factors, which is a common feature of
transcriptional regulation. Instead, we represent multiple transcription factors bound to the
same gene with separate nodes. Let M be the set of differentially expressed transcripts, and
fc(m) be the fold change in mRNA abundance of each gene m ∈ M. For each m, we searched
the interactome for the set of upstream transcription factors F that target m, remove m from
the interactome, and add one node mf for each transcription factor f ∈ F and one edge
between f and mf. The fold change of m is transferred to all the mf to compute the penalty
values on mf. Each new terminal node mf may be interpreted as a binding site of f on m.
E. Sensitivity analysis
Applying an optimization approach to inherently noisy biological data makes it necessary to
explore the alternative or sub-optimal solution space surrounding the reported optimal
solution. This is to ensure that the nodes and edges selected by the algorithm, from which
significant efforts will be invested to extract biological meaning, are relatively stable to
possible sources of noise. Figure 3 presents two ways to quantify this stability at the global
level. First, starting from the optimal solution reported by the algorithm, we can re-
formulate the optimization problem to find a number of sub-optimal solutions - networks
that are optimal under the additional constraint that they must differ from the original
optimal solution by a pre-defined percentage of nodes. We can then compare these sub-
optimal solutions to the optimal one in terms of the objective function value [Figure 3(A)]
and the frequency at which the nodes in the original optimal solution are preserved in the
sub-optimal solutions [Figure 3(B)] in order to decide whether the solution is robust to
noise.
F. Practical advice
Parameters: Tuning the value of parameter β essentially controls the size of the PCST
solution output. With larger β values it becomes more expensive to exclude each terminal
node (i.e., making the objective function larger), so the optimization algorithm will include
more edges in the PCST solution. Although a larger network may include more hits from the
experimental data, it is more difficult to interpret and also more likely to include false
positive hits that may connect to the real underlying network via tenuous interactions. To
find a suitable value of this parameter, it is advisable to run the algorithm with a range of
values and choose a solution that (1) includes any expected pathways based on prior
biological knowledge, (2) is stable for the neighborhood of β values, and (3) contains as
many of the hits as possible. One can also start with a small value of β to build a core
network and gradually increase β to explore how more hits are connected to the core
network.
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It may be possible to use cross-validation to objectively choose β. In such an approach, one
would randomly partition the terminal nodes into two complementary subsets, build a PCST
using one subset (training set) and compute the recovery of the second subset (validation
set) in that PCST. To reduce the effect of random variations, for each value of β, multiple
rounds of such cross-validation can be performed and one average performance value is
reported. Based on this performance measure, a β value can be selected.
While this approach has a certain appeal, we urge caution since the assumptions and
requirements of cross-validation may not be satisfied by the biological datasets. First, in
order for the recovery of the validation set by a PCST to be a good indicator of its
performance, the training set and the validation set must be drawn from the same
distribution. This criterion requires the terminal sets to be sufficiently large that each
random sample contains termini from all the underlying biological processes. Since the
current datasets are subject to many limitations such as the sensitivity of the MS instrument
depending on protein abundance and the coverage of the interactome, we do not know a
priori whether this assumption is appropriate. Second, it is unclear which of the
conventionally used measures of predictor performance is suitable in this setting. We aim to
recover intermediate nodes that are undetected in experiments, so we cannot count such
nodes included in the PCST as false positives. In the absence of a false positive definition,
counting the recovery of the terminal nodes makes little sense since the optimal value of β
will be the one that produces a PCST that include the most terminal nodes (weighted by
penalty values).
Implementation: There are various approximation algorithms to solve the PCST problem.
These have recently been reviewed (Archer et al. 2011). The dhea-code program (Ljubić et
al. 2005), which can be downloaded from Dr. Ljubić’s website (Ljubić 2008), uses a branch-
and-cut approach to obtain exact, optimal solutions. This program requires the ILOG
CPLEX (IBM) optimization library that is available at no-charge for teaching and non-
commercial research as part of the IBM Academic Initiative (IBM 2010). In the supplement
of this article we provide a simple Python script for creating the input file for dhea-code
from tab delimited text files of the weighted interactome and terminal nodes. The output
files of dhea-code include the PCST solution in a DOT file [a plain text format for
specifying graphs; (Graphviz 2011b)]. From there the solution can be rendered and viewed
by the tools in Graphviz (Graphviz 2011a), or further manipulated and analyzed by the
Python library NetworkX (Hagberg et al. 2008). One standard operation is to convert the
DOT file to one of the files formats supported by Cytoscape (Smoot et al. 2011; Cline et al.
2007) in order to utilize Cytoscape’s many visualization capabilities for biological networks.
A recently published message passing algorithm, although taking a heuristic approach, is
able to find solutions with objective values comparable to dhea-code under much less
computing time and memory (Bailly-Bechet et al. 2011). It requires a depth parameter to be
specified a priori to control the length of paths in the solution network. This appears to have
the consequence of eliminating long braches in the solution. The effect of this difference on
the identities and functional relevance of the recovered nodes remains to be investigated.
III. Biological insights
The PCST solution connects together the phosphorylation events and transcriptional changes
using a compact set of interactions. Since the method puts the phosphorylation events in the
context of protein-protein interactions, the connections participated by these events or
groups of events are suggestive of their cellular functions. The transcription factors included
in the network and the connections among them point to the functional consequence of the
upstream signals. These are certainly of great interest for elucidating the role of individual
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hits. Also interesting are the properties that emerge from the network at the systems level,
and we will describe a few computational techniques for such analyses using the yeast
pheromone response PCST solution as an example (Figure 2).
A. Properties of the full network
The PCST solution in Figure 2 was constructed from published phosphoproteomic (Gruhler
et al. 2005) and transcription profiling (Roberts et al. 2000) datasets of the yeast
Saccharomyces cerevisiae in response to the mating pheromone α-factor. This network was
first reported in (Huang et al. 2009). The network connects 56 of the 112 proteins with α-
factor-responsive phosphorylation sites and 100 of the 201 differentially expressed genes
through 94 intermediate proteins.
The solution network shows a few notable features at the global level. First, the MAPK
cascade known to be induced by pheromone (labeled “pheromone core” in Figure 2) is
recovered by the algorithm. In particular, it correctly identifies the proteins GPA1, STE11
and BEM1, where no phosphorylation sites were detected, as well as their connections to
other proteins in the pheromone signaling pathway. In addition, only proteins that are
present in the pheromone response pathway are included. Secondly, beyond the MAPK
cascade, the solution network partitions into highly coherent subnetworks with biological
functions relevant to mating. At the transcription level, phosphorylated proteins seem highly
informative in selecting interacting transcription factors. Examples include DIG1/DIG2/
STE12 complex in the pheromone signaling pathway, SWI4/SWI6 and SWI6/MBP1 in the
PKC pathway, and FKH2/NDD1 complex regulated by CDC28. These observations suggest
the constraints imposed by the phosphorylated proteins and differentially expressed genes
are sufficient to guide the selection of important players that contribute to the response.
To assess the functional significance of the intermediate nodes from the PCST solution in
mating response, we examined two independent whole-genome deletion screen datasets that
screen for genes whose deletion result in mating defects. One screen measures a molecular
phenotype in the form of activation of FUS1-lacZ reporter (Chasse et al. 2006) and the other
screen measures a morphological phenotype in the form of cell cycle arrest and shmoo
formation (Narayanaswamy et al. 2006). For each screen we counted the number of hits that
overlap with the intermediate nodes in the PCST solution, and using all the screening genes
as background we computed a hypergeometric P-value for which such overlap would appear
by chance. As seen in Figure 4, compared to networks constructed from shortest paths and
first neighbors of the terminal nodes, the PCST solution is more compact while achieving
higher enrichment of genes implicated in mating defects.
B. Biological functions of subnetwork/modules
To objectively quantify the empirical observation that the PCST solution is partitioned into
functional coherent subnetworks, we applied the Girvan-Newman algorithm (Dunn et al.
2005; Girvan et al. 2002) to cluster the solution. This algorithm is used for detecting clusters
in an interaction network that contain dense connections between nodes in the same cluster
but less dense connections to nodes in other clusters. Gene Ontology enrichment analysis of
the resulting clusters reveals that all the clusters have high degree of functional coherence
(Table II). It is interesting to note that many of the clusters are not coordinately expressed at
the mRNA level, as quantified by the significance of expression coherence score (Pilpel et
al. 2001) or by the significance of expression activity score (Ideker et al. 2002). Notably, the
clusters that show significant coordinated expression are involved in cell cycle processes.
Being able to recover functionally coherent clusters that are not coherent at the transcript
level is a significant result. Transcriptional data, which are more readily available than
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proteomics data, are the focus of many computational methods for regulatory network
construction. Our results suggest that methods that rely solely on expression data, including
a prior Steiner tree approach (Dittrich et al. 2008), will be unable to recover the full extent of
a biological response.
C. Quantifying the relevance of the transcription factors
In addition to the transcription factors mentioned above that are known to be induced by
pheromone or function in related biological processes, the PCST solution network features
many other transcriptional regulators not previously implicated in pheromone response. We
use expression coherence score as a metric to quantify the significance of these transcription
factors at the global level. For each transcription factor with targets in the interactome, we
obtained the expression values of those targets across a set of conditions that stimulate
pheromone signaling, and computed the significance P-value of the expression coherence
score. Then we set a threshold on the significance P-value, and compared the percentage of
transcription factors included and excluded in the PCST that pass this threshold. As shown
in Figure 5, the transcription factors included in the network are more likely to have a set of
targets that are coherently expressed than the factors excluded from the network. To check if
these transcription factors are condition specific, we did a similar calculation for the
expression values from a set of conditions that are unrelated to pheromone: when yeast
undergoes the metabolic shift from fermentation to respiration (diauxic shift). We found that
coherence is specific to the conditions related to pheromone signaling but not to diauxic
shift.
IV. Open challenges
A. Improving the input data
The central premise behind our constraint optimization framework is that the experimental
measurements at the signaling and transcription level are sufficient for guiding selection of
relevant interactions from the interactome. It is important to note, however, that many of
these interactions may only occur under specific conditions that are not relevant to the
problem being studied. It is not yet practical to collect condition-specific interaction data on
a large scale. Nevertheless, there are a few strategies to ensure the selected interactions are
indeed relevant. First, as a pre-processing step, the input interaction network can be filtered
to remove nodes that are not believed to be expressed under the condition of interest, based
on transcript or protein assays. With the improved sensitivity of RNA-seq to detect low
abundance transcripts compared to microarrays, this step may now be done with higher
confidence. However, expression data are still noisy, and removing nodes completely risks
missing important components of a network. Alternatively, we can add to the PCST
formulation capacities on the nodes that represent the expression level. There are well-
established procedures that transform node capacitated network flow problems to ones
without the node capacities (Ahuja et al. 1995).
Our current analysis defines node penalties on the phosphorylated proteins in a practical but
ad hoc manner: the penalty values are proportional to the absolute value of log-fold changes
of phosphorylation; if there are multiple phosphorylation sites on one protein, the maximum
value is used. This reflects the assumption that larger changes in phosphorylation carry
higher importance and thus should be given higher priority to be included. There are other,
probably more principled, ways of quantifying the significance of the phosphorylation
changes. We distinguish two kinds of significance: statistical significance and biological
significance. The former requires the development of robust error models (Yi Zhang et al.
2010) while the latter would benefit from knowledge about the context of the
phosphorylation sites, such as the structural domain or binding sequence motif where the
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sites are located [see examples in (Naegle et al. 2010)]. But these two need not to be
exclusive: once statistical significance is established, penalty values can be defined by
analyzing for potential biological significance.
As phosphorylation sites are the starting point from which the PCST network solution is
built, it is critical to have a good coverage of interactions involving these proteins in the
interactome graph. Phosphorylation sites participate in interactions with other proteins in
two ways: as substrates of kinase and phosphatases, and as binding partners of proteins that
recognize the phosphorylated residues. Many of these interactions are transient and context
specific and thus difficult to capture in some interaction assays. In particular, among the
various high-throughput interactome mapping techniques, a modified affinity capture MS
method is the most informative in identifying kinase targets, with yeast two-hybrid being
second (Sharifpoor et al. 2011). Many in vivo methods are available to link kinases to
phosphorylation substrates [reviewed in (Sopko et al. 2008)] but only for specific kinases.
Taking these efforts to the global level, and using other information such as sequence motifs
integrated within a computational framework such as NetworKIN (Linding et al. 2007), will
produce interaction datasets that greatly enhance the ability of our algorithm to connect the
phosphorylated proteins.
Beyond the focused mapping of interactions involving phosphorylated proteins, the ability
to discover novel signaling pathways also depends on the coverage of other parts of the
interactome. Even with the combination of large experimental efforts and curated databases
we are still far from a complete mapping of all possible protein-protein interactions,
especially in less well-studied organisms. Therefore, many computational methods have
been developed to predict possible interactions. These methods make use of features such as
gene neighborhood (M. Huynen et al. 2000), gene fusion (Marcotte et al. 1999), sequence
co-evolution (Goh et al. 2000), and may incorporate several such features in a Bayesian
framework (Jansen et al. 2003). The probabilistic nature of edge weights in our PCST
formulation provides a natural way to include these computational predictions.
B. Other applications and potentials
The PCST approach can be used to analyze jointly a wide variety of types of data. Cellular
functions are operated by networks of molecular interactions, which include a lot more than
phosphorylation mediated signaling and transcription factor binding to target genes. But
regardless of the data type, there are many situations in which we see to find a parsimonious,
high-confidence interaction network satisfying a defined set of constraints. Therefore, this
approach can be applied to many other levels of regulation, depending on the source of the
constraints and the molecular interactions. For example, we may model the global effect of a
microRNA by using the microRNA targets as constraints and including microRNA to target
relationships in the interactome. Metabolomics data is another area of great interest and may
become an entry point to link together protein signaling networks with metabolic networks.
The detected metabolites can be used as constraints in a network of metabolic reactions
catalyzed by enzymes that are also part of the protein interaction network. For all these
datasets, taking a network approach such as the PCST will yield more insight than simply
following up on the top hits.
One disadvantage of the PCST method is the tree structure of the resulting network: all the
included terminal nodes must be connected to each other. However, it is possible that the
terminal nodes belong to multiple, separate signaling pathways that are not connected to
each other, either because there is no cross-talk biologically or the cross-talk interactions are
not in the known interactome. Adopting a forest formulation, where multiple trees may be
used to connect the terminal nodes, may remedy this drawback.
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Finally, it is useful to consider this approach in the context of other types of network
modeling. The strengths of our method lie in the ability to identify previously unrecognized
components of a cellular response and to discover functionally coherent subsets of proteins.
However, this approach is not designed to capture the dynamics of a system, including
feedback regulation. A natural way to describe such feedback mathematically is by
differential equations, which can be simulated numerically or analyzed. Differential
equation-based models have been applied genome-wide in a comprehensive transcriptional
and translational network for Escherichia coli (Thiele et al. 2009) and have been applied
extensively to relatively small networks of mammalian proteins (Eungdamrong et al. 2004;
Aldridge et al. 2006; Tyson et al. 2003). However, such approaches are not suitable for very
large networks where there are not enough data to sufficiently constrain the necessary
parameters of the models.
We believe that these two approaches may ultimately be used together to develop dynamic
models of previously uncharacterized biological systems. In a first phase, proteomic,
transcriptional or other “-omics” datasets would be analyzed using constraint optimization to
identify a set of proteins that seem most relevant to the biological process. With the size of
the problem now reduced to a more manageable level, more focused experiments together
with differential equation-based modeling could reveal the dynamics of the system.
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Figure 1.
(A) Finding relevant interactions as a constraint optimization problem. We seek a set of high
confidence edges present in the interactome that directly or indirectly link the proteins and
genes identified in the experimental assays. Because some of the input data may be false
positives (arrowhead) or may not be explained by currently known interactome (arrow), our
approach does not require that all the input data be connected, but rather uses these data as
constraints. Note that the protein product and mRNA transcript of the same gene are
represented as separate nodes. Image reproduced with permission from (Huang et al. 2009).
(B) Work flow diagram for defining the optimization objective function from input datasets.
Interaction weights go into the edge cost summation term (Step 1) and the changes in
tyrosine phosphorylation from MS data go into the node penalty summation term (Step 3).
The transcription factor to mRNA target relationships are added to the edges to form the
total interactome (Step 2), and the mRNA nodes are assigned penalty values (Step 3).
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Figure 2.
The protein components of the pheromone response network constructed by the PCST
approach. Note that the canonical pheromone response pathway (enclosed by dashed lines)
is but a small component of the broad cellular changes revealed by applying the algorithm to
the mass spectrometry and expression data. For clarity the differentially transcribed genes
included in the network are not presented. Functional groups based on GO annotation are
outlined with red boxes. PKC, protein kinase C; TF with phos. site, transcription factor with
at least one differentially phosphorylated sites; TF with no phos. site, transcription factor
with no differentially phosphorylated sites; non-TF protein with phos. site, a protein that is
not a transcription factor and with at least one differentially phosphorylated sites; non-TF
with no phos. site, a protein that is not a transcription factor and with no differentially
phosphorylated sites. Image reproduced with permission from (Huang et al. 2009).
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Figure 3.
Alternative or suboptimal solutions to the yeast pheromone response dataset. Because we
use an optimization approach to analyze inherently noisy data, we asked whether the
network we obtained was stable - are there very different networks that explain the data
almost as well? For this, we compared the optimal solution network to a set of alternative
solution networks obtained by finding networks that are different from the optimal one by at
least a specific percentage of nodes. (A) No alternative solutions in the neighborhood of the
optimal solution achieve the same objective function value. (B) Of the nodes that appear at
least once in the 54 suboptimal solutions, at least 80% also appear in the optimal solution.
Image reproduced with permission from Huang et al. (2009).
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Figure 4.
The PCST pheromone response network is compact, and when compared to networks
predicted by other methods, it contains higher fraction of genes that are implicated in mating
response, measured by defects in activating a FUS1-lacZ reporter gene (Chasse et al. 2006)
and defects in cell cycle arrest and shmoo formation (Narayanaswamy et al. 2006). The
Flow network was constructed from the phosphorylated proteins and differential expressed
genes by a previously published algorithm based on network flows (Yeger-Lotem et al.
2009). The Shortest path network consists of pairwise shortest paths between the terminal
nodes and the First neighbor network consists of nodes in the interactome that directly
interact with the phosphorylated proteins. Enrichment P-values were computed by
hypergeometric tests using all the genes tested in the respective genetic screen as
background. The number above each bar denotes the number of nodes in the network. Image
reproduced with permission from Huang et al. (2009).
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Figure 5.
Percentage of transcription factors (TF) with targets that show significant expression
coherence (EC) scores computed from 50 nM α-factor time course (Roberts et al. 2000) and
diauxic shift conditions (DeRisi et al. 1997), for transcription factors included in and
excluded from the PCST solution network. The P-values indicate thresholds on the
significance of the expression coherence score of the target genes. Image reproduced with
permission from Huang et al. (2009).
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Figure 6.
Computational representation and discovery of transcription factor binding sites, with an
example of the human REL protein binding profile [JASPAR MA0101.1, curated from
Kunsch et al. (1992)] and NFκB binding site in the human IL8 promoter (TRANSFAC
binding site HS$IL8_21). In vitro techniques such as SELEX (systematic evolution of
ligands by exponential enrichment) (Stoltenburg et al. 2007) can generate a set of sequences
that bind to a specific transcription factor with high affinity. From an alignment of these
sequences, a PFM is created to represent the base preference of this factor at each position of
the binding site. After pseudo-count correction, the PSSM approach takes the base
preference at each position, adjusts for background (usually genome-wide) frequency of that
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base, and computes a numerical value for the bases at each position that can be used to score
a DNA sequence (D’haeseleer 2006; Stormo 2000). Alternatively, an approximate PSAM
for scoring can be created from a pseudo-count corrected PFM by calculating the preference
of a base relative to the most frequent base at each position (Foat et al. 2006, 2005; Manke
et al. 2008; Roider et al. 2007). See (MacIsaac and Fraenkel 2006) for a more detailed
treatment of the topic.
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Table I
A selection of publicly available protein-protein interaction databases. For further details see recent summary
and reviews in (Turinsky et al. 2011; De Las Rivas et al. 2010; Klingström et al. 2010). Many databases in this
table have adopted the Proteomic Standards Initiative Molecular Interaction (PSI-MI) data formats and
implemented the PSI Common Query Interface (PSICQUIC) (Aranda et al. 2011) that allows easy,
programmatic access and integration of these data.
Type of
interactions
Data sources Name of database and referencea
Direct/physical Curation of primary literature Biological General Repository for Interaction Datasets (BioGRID)
(Stark et al. 2011)
Human Protein Reference Database (HPRD) (Keshava Prasad et al.
2009)
Molecular Interaction database (MINT) (Chatr-aryamontri et al. 2007)
IntAct molecular interaction database (Kerrien et al. 2007)
Mammalian Protein-Protein Interaction Database (MIPS) (Pagel et al.
2005)
Database of Interacting Proteins (DIP) (Salwinski et al. 2004)
Biomolecular Interaction Network Database (BIND) (Bader et al.
2001)
Collection of multiple primary
databases
Interaction Reference Index (iRefIndex) (Razick et al. 2008)
Agile Protein Interaction DataAnalyzer (APID) (Prieto et al.2006)
Michigan Molecular Interactions database (MiMI) (Tarcea et al. 2009)
Unified Human Interactome database (UniHI) (Chaurasia et al. 2007)
Direct/physical + indirect/functional Collection of multiple primary
databases and computational
predictions
STRING (von Mering et al. 2005)
a
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